SoftBank Vision Fund — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Metserametsera.com in 𝕏Nov 2024acquired by Pfizer

Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies.

BiotechHealthtechMedical DevicesNew York, US

Clive A. Meanwell(Director)Christopher J. Visioli(Executive Officer)inBrian Hubbard(Executive Officer)inChristopher Whitten Bernard(Executive Officer, Director)Steven Marso(Executive Officer)

BoardKristina Burow(Director)

Co-investorsAlpha Wave Global ARCH Venture Partners F-Prime Capital GV (Google Ventures)RA Capital Newpath Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.